Devonian Health Financials
GSD Stock | CAD 0.20 0.02 9.09% |
Operating Margin (0.06) | Profit Margin (0.33) | Short Ratio 1.66 | Return On Equity (0.23) |
Devonian | Select Account or Indicator |
Understanding current and past Devonian Health Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Devonian Health's financial statements are interrelated, with each one affecting the others. For example, an increase in Devonian Health's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Devonian Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Devonian Health Group. Check Devonian Health's Beneish M Score to see the likelihood of Devonian Health's management manipulating its earnings.
Devonian Health Stock Summary
Devonian Health competes with Premium Income, E L, Fairfax Financial, Fairfax Fin, and Fairfax Financial. Devonian Health Group Inc., a pharmaceutical company, engages in the development of botanical drugs. The company was incorporated in 2013 and is headquartered in Qubec, Canada. DEVONIAN HEALTH operates under Biotechnology classification in Canada and is traded on TSX Venture Exchange.Foreign Associate | USA |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
Instrument | Canada Stock View All |
Exchange | TSX Venture Exchange |
ISIN | CA2518341078 |
Business Address | 360, rue des |
Sector | Biotechnology |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | groupedevonian.com |
Phone | 514 248 7509 |
Currency | CAD - Canadian Dollar |
You should never invest in Devonian Health without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Devonian Stock, because this is throwing your money away. Analyzing the key information contained in Devonian Health's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Devonian Health Key Financial Ratios
There are many critical financial ratios that Devonian Health's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Devonian Health Group reports annually and quarterly.Revenue | 2.35 M | ||||
Gross Profit | 561.01 K | ||||
EBITDA | (2.46 M) | ||||
Net Income | (4.6 M) | ||||
Total Asset | 19.18 M |
Devonian Health Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 16.7M | 14.6M | 21.6M | 19.2M | 22.1M | 15.6M | |
Net Tangible Assets | (1.5M) | (2.3M) | (3.4M) | 6.0M | 6.9M | 7.2M | |
Retained Earnings | (14.0M) | (17.4M) | (20.8M) | (25.4M) | (22.9M) | (21.7M) | |
Accounts Payable | 1.5M | 555.5K | 410.4K | 753.6K | 866.6K | 626.7K | |
Cash | 913.0K | 344.8K | 2.8M | 5.1M | 5.8M | 6.1M | |
Long Term Debt | 4.4M | 4.7M | 5.3M | 4.3M | 4.9M | 4.3M | |
Net Receivables | 282.6K | 175.9K | 220.0K | 663.6K | 763.2K | 801.3K | |
Total Liab | 7.3M | 7.1M | 5.3M | 4.9M | 5.7M | 5.9M | |
Total Current Assets | 1.7M | 664.2K | 8.4M | 6.3M | 7.3M | 7.7M | |
Intangible Assets | 7.0M | 6.2M | 5.6M | 5.5M | 6.3M | 6.7M | |
Common Stock | 16.8M | 19.0M | 20.2M | 27.6M | 31.7M | 16.1M | |
Inventory | 86.6K | 28.2K | 154.6K | 159.8K | 183.8K | 126.1K | |
Net Invested Capital | 14.0M | 12.8M | 20.5M | 17.8M | 20.5M | 16.9M | |
Net Working Capital | (898.4K) | (1.1M) | 7.4M | 1.5M | 1.7M | 1.3M | |
Net Debt | 4.2M | 3.7M | 4.9M | 1.5M | 1.3M | 1.2M | |
Capital Stock | 19.0M | 20.2M | 27.6M | 29.3M | 33.7M | 23.8M |
Devonian Health Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Interest Expense | 761.6K | 793.1K | 937.0K | 459.7K | 528.6K | 367.9K | |
Total Revenue | 2.1M | 1.5M | 2.3M | 2.3M | 2.7M | 2.1M | |
Gross Profit | (70.1K) | (240.9K) | 561.0K | 892.3K | 1.0M | 551.1K | |
Operating Income | (4.1M) | (2.3M) | (2.9M) | (4.3M) | (3.9M) | (4.1M) | |
Ebit | (3.2M) | (4.1M) | (2.3M) | (2.9M) | (2.6M) | (2.8M) | |
Research Development | 1.5M | 610.3K | 778.5K | 1.4M | 1.6M | 899.7K | |
Cost Of Revenue | 2.2M | 1.7M | 1.7M | 1.5M | 1.7M | 1.6M | |
Income Before Tax | (4.4M) | (3.3M) | (3.4M) | (4.6M) | (4.1M) | (3.9M) | |
Net Income | (4.4M) | (3.3M) | (3.4M) | (4.6M) | (4.1M) | (3.9M) | |
Net Interest Income | (517.6K) | (793.1K) | (897.3K) | (275.4K) | (247.8K) | (260.2K) | |
Ebitda | (1.6M) | (2.6M) | (1.5M) | (1.6M) | (1.9M) | (2.0M) |
Devonian Health Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change In Cash | 668.4K | (568.2K) | 2.5M | 2.3M | 2.6M | 2.7M | |
Net Borrowings | 535.4K | 525.0K | 52.8K | (526.8K) | (605.8K) | (575.5K) | |
Depreciation | 1.0M | 1.0M | 851.4K | 423.5K | 487.0K | 701.4K | |
Net Income | (4.4M) | (3.3M) | (3.4M) | (4.6M) | (4.1M) | (3.9M) | |
Change To Netincome | (613.2K) | 367.8K | 866.3K | 308.9K | 355.2K | 373.0K | |
End Period Cash Flow | 913.0K | 344.8K | 2.8M | 5.1M | 5.8M | 6.1M | |
Free Cash Flow | (2.1M) | (1.8M) | (3.0M) | (4.4M) | (3.9M) | (3.7M) | |
Other Non Cash Items | 430.4K | 492.6K | 144.1K | (348.7K) | (313.8K) | (298.1K) |
Devonian Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Devonian Health's current stock value. Our valuation model uses many indicators to compare Devonian Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Devonian Health competition to find correlations between indicators driving Devonian Health's intrinsic value. More Info.Devonian Health Group is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Devonian Health's earnings, one of the primary drivers of an investment's value.Devonian Health Group Systematic Risk
Devonian Health's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Devonian Health volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Devonian Health Group correlated with the market. If Beta is less than 0 Devonian Health generally moves in the opposite direction as compared to the market. If Devonian Health Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Devonian Health Group is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Devonian Health is generally in the same direction as the market. If Beta > 1 Devonian Health moves generally in the same direction as, but more than the movement of the benchmark.
Devonian Health Group Total Assets Over Time
Devonian Health Thematic Clasifications
Devonian Health Group is part of Health Management investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Healthcare providers, hospitals. Major hospitals and healthcare providers
This theme covers Healthcare providers, hospitals. Major hospitals and healthcare providers. Get More Thematic Ideas
Health Management | View |
Devonian Health December 11, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Devonian Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Devonian Health Group. We use our internally-developed statistical techniques to arrive at the intrinsic value of Devonian Health Group based on widely used predictive technical indicators. In general, we focus on analyzing Devonian Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Devonian Health's daily price indicators and compare them against related drivers.
Downside Deviation | 20.43 | |||
Information Ratio | 0.0711 | |||
Maximum Drawdown | 65.15 | |||
Value At Risk | (9.09) | |||
Potential Upside | 27.27 |
Additional Tools for Devonian Stock Analysis
When running Devonian Health's price analysis, check to measure Devonian Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Devonian Health is operating at the current time. Most of Devonian Health's value examination focuses on studying past and present price action to predict the probability of Devonian Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Devonian Health's price. Additionally, you may evaluate how the addition of Devonian Health to your portfolios can decrease your overall portfolio volatility.